Largest Genetic Study Identifies New Disease Pathways Through Blood Protein Analysis
A large-scale genetic study identified new disease pathways and opportunities for drug repurposing through analysis of blood proteins. Queen Mary University of London’s Precision Healthcare University Research Institute (PHURI) and the Berlin Institute of Health (BIH) at Charité collaborated on the meta-analysis.
The study, the largest of its kind, investigated the genetic regulation of blood proteins. Researchers published their findings, which have the potential to advance precision medicine.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: May 6, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]LATEST
Digitalis Glycosides Studied for Heart Failure Treatment at ESC Heart Failure 2026 Congress
2026-05-10
Digoxin Lowers Death Risk and Heart Failure in Rheumatic Heart Disease Patients, Study Finds
2026-05-10
New Test Detects Biomarkers for Frontotemporal Lobar Degeneration, a Rare Dementia Affecting Over 57 Million Globally
2026-05-10







